血清胃泌素释放肽前体在小细胞肺癌诊断和分期中的临床意义

高振远; 欧毅梅; 张竞竞; 张浩然; 毕明宏

doi:10.13898/j.cnki.issn.1000-2200.2016.01.009

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

血清胃泌素释放肽前体在小细胞肺癌诊断和分期中的临床意义

高振远 , 欧毅梅 , 张竞竞 , 张浩然 , 毕明宏

文章导航 > 蚌埠医学院学报 > 2016, 41 > 1: (35-37)

引用本文:

Citation:

血清胃泌素释放肽前体在小细胞肺癌诊断和分期中的临床意义

蚌埠医学院第一附属医院肿瘤内科, 安徽蚌埠 233004

作者简介: 高振远(1978-),男,主治医师.

基金项目:
蚌埠医学院科技发展基金面上项目(bykj12B25)
中图分类号: R734.2

The clinical significance of serum progastrin releasing peptide in the diagnosis and staging of small cell lung cancer

Department of Oncology, The First Affiliated Hospital of Bengbu Medical College, Bengbu Anhui 233004, China
CLC number: R734.2

摘要: 目的:探讨血清胃泌素释放肽前体(proGRP)在小细胞肺癌(SCLC)与非小细胞肺癌(NSCLC)的鉴别诊断和临床分期中的价值。方法:应用化学分析法,检测62例初诊SCLC(局限期25例,广泛期37例)、38例NSCLC患者血清proGRP水平,并与神经元特异性烯醇化酶(NSE)相对照,观察其敏感度、特异度以及与肿瘤临床分期的关系。结果:单个检测proGRP、NSE和联合检测proGRP及NSE(proGRP+NSE)诊断SCLC的敏感度分别为82.93%、64.15%和71.58%。SCLC中proGRP+NSE阳性率显著高于NSE阳性率(P<0.01),但与proGRP阳性率差异无统计学意义(P>0.05)。SCLC组患者血清proGRP和NSE水平均显著高于NSCLC组(P<0.01)。SCLC广泛期患者血清proGRP和NSE值均显著高于其局限期患者(P<0.01)。结论:proGRP作为SCLC的标志物,具有敏感度高的特点,并可反映SCLC的分期。proGRP和NSE联合检测可提高SCLC诊断的准确率。
- 肺肿瘤 /
- 胃泌素释放肽前体 /
- 神经元特异性烯醇化酶
Abstract: Objective:To explore the clinical value of the levels of serum progastrin releasing peptide(proGRP) in the differential diagnosis and clinical staging of small cell lung cancer(SCLC) and non-small cell lung cancer(NSCLC).Methods:The serum levels of proGRP in 62 patients with SCLC(including 25 cases of limited stage and 37 cases of extensive stage) and 38 patients with NSCLC were measured by chemiluminescent immunoassay, which was compared with neuron specific enolase(NSE).The sensitivity, specificity and tumor staging in all patients were analyzed.Results:The sensitivities of the single detection of proGRP, NSE and combination detection of proGRP and NSE in diagnosing SCLC were 82.93%, 64.15% and 71.58%, respectively.The positive rate of the combination detection of proGRP and NSE in diagnosing SCLC was significantly higher than that of the single detection of NSE, the difference of the positive rate between combination detection proGRP and NSE and single detection of proGRP was not statistically significant(P>0.05).The serum levels of proGRP and NSE in patients with SCLC were obviously higher than those in NSCLC patients(P<0.01).Among the SCLC patients, the serum levels of proGRP and NSE in extensive stage patients were significantly higher than those in limited stage patients(P<0.01).Conclusions:The ProGRP is a tumor marker of SCLC, which is high sensitivity and specificity, and can reflect the staging.The combination detection of proGRP and NSE can improve the accurate rate of SCLC diganosis.
- lung neoplasms /
- progastrin releasing peptide /
- neuron specific enolase

[1]	白晓雪,张艳蓓. 肺癌肿瘤标志物检测的研究现状[J]. 临床肺科杂志,2011,16(2):259.
[2]	张荣华,郑加荣,陈佳佳. 血清肿瘤标志物联合检测对肺癌的临床意义[J]. 中国实用医刊,2011,38(7):28.
[3]	MCDONALD TJ,NILSSON G,VAGNE M,et al. A gastrin releasing peptide from the porcine non-antral gastric tissue[J]. Gut,1978, 19(9):767.
[4]	YAMAGUCHI K, ABE K, KAMEYA, T, et al. Production and molecular size heterogeneity of immunoreactive gastrin-releasing peptide in fetal and adult lungs and primary lung tumors[J]. Cancer Res,1983(43):3932.
[5]	MIYAKE Y,KODAMA T,YAMAGUCHI K. Pro-gastrin-releasing peptide(31-98) is a specific tumor marker in patients with small cell lung carcinoma[J]. Cancer Res,1994(54):2136.
[6]	邵良荣,邵杰,肖丽华,等. 联合检测血清四种肿瘤标志物对肺癌的诊断价值[J]. 中国实用医刊,2011,38(1):22.
[7]	SCHNEIDER J, PHILIPP M, SALEWSKI L, et al. Progastrin-releasing peptide(ProGRP) and neuron specific enolase(NSE) in therapy control of patients with small-cell lung cancer[J]. Clin Lab,2003,49(1/2):35.
[8]	TANG JH,ZHANG XL,ZHANG ZH,et al. Diagnostic value of tumor marker pro-gastrin-releasing peptide in patients with small cell lung cancer:a systematic review[J]. Chin Med J(Engl), 2011,124(10):1563.
[9]	KIM HR,Oh IJ,SHIN MG,et al. Plasma proGRP concentration is sensitive and specific for discriminating small cell lung cancer from nonmalignant conditions or non-small cell lung cancer[J]. J Korean Med Sci,2011,26(5):625.

[1]	黄家琴 , 杨杰 . 血清前白蛋白和神经元特异性烯醇化酶检测在新生儿缺氧缺血性脑病诊断中的临床意义. 蚌埠医学院学报, 2019, 44(2): 219-221. doi: 10.13898/j.cnki.issn.1000-2200.2019.02.024
[2]	许华斌 . 血清肿瘤标志物联合检测在肺癌诊断中的应用. 蚌埠医学院学报, 2014, 39(8): 1113-1116.
[3]	谢军 , 张侠 , 李红林 . 不同血液标本及存放时间对神经元特异性烯醇化酶测定的影响. 蚌埠医学院学报, 2013, 37(12): 1654-1655.
[4]	杨百武 , 张庆 , 杜京承 , 王昆 , 李丹 , 赵开雷 . 右美托咪定对颅内血肿清除术患者S100β蛋白和神经元特异性烯醇化酶的影响. 蚌埠医学院学报, 2016, 41(8): 1038-1041. doi: 10.13898/j.cnki.issn.1000-2200.2016.08.019
[5]	朱成 , 王淮 . 神经元特异性烯醇化酶检测对颅脑损伤诊断分型及判断预后的临床意义. 蚌埠医学院学报, 2014, 38(1): 50-52.
[6]	赵福友 , 陈余清 , 黄礼年 , 夏雪梅 , 蔡映云 . 肺癌患者外周血肺组织特异性基因mRNA检测的诊断价值. 蚌埠医学院学报, 2007, 32(3): 274-276.
[7]	吴小祥 , 齐本权 , 余美玲 . 黄连素抑制肺腺癌核转录因子-κB活性的影响及其与顺铂耐药关系研究. 蚌埠医学院学报, 2015, 40(12): 1624-1627. doi: 10.13898/j.cnki.issn.1000-2200.2015.12.003
[8]	汪强武 , 王安潮 , 陈余清 . 端粒酶11-聚体寡核苷酸联合依托泊苷对肺癌细胞的作用. 蚌埠医学院学报, 2005, 30(3): 208-210.
[9]	黄礼年 , 陈余清 , 宋玮 , 承泽农 , 王朝夫 , 刘超 . 米诺环素抑制小鼠肺癌生长、转移及抗血管生成的研究. 蚌埠医学院学报, 2005, 30(3): 206-208.
[10]	王安潮 , 王炯 , 陈余清 . 肺癌患者痰液脱落细胞端粒酶活性和p53基因突变的检测. 蚌埠医学院学报, 2005, 30(3): 215-218.
[11]	王安潮 , 张永 , 陈余清 . 反义小鼠端粒酶RNA及顺铂对小鼠肺癌移植瘤的抑制作用. 蚌埠医学院学报, 2005, 30(3): 221-223.
[12]	储菲 , 姚扬 , 李正红 . 黄连素对TGF-β1诱导的肺癌A549细胞侵袭和迁移的影响. 蚌埠医学院学报, 2020, 45(7): 841-844. doi: 10.13898/j.cnki.issn.1000-2020.07.001
[13]	李磊 , 李殿明 . 血清碱性磷酸酶和血清钙水平测定对原发性肺癌骨转移的临床诊断价值. 蚌埠医学院学报, 2017, 42(2): 158-161. doi: 10.13898/j.cnki.issn.1000-2200.2017.02.006
[14]	孙丽芳 , 陈余清 , 赵成岭 , 李伟 , 李殿明 . 生存素基因联合细胞角蛋白19片段抗原及癌胚抗原检测对肺癌引起胸腔积液的诊断意义. 蚌埠医学院学报, 2010, 35(10): 993-995.
[15]	张生义 , 张己为 , 张旭峰 , 张逸 , 许斌斌 , 左顺庆 . 华蟾素对非小细胞肺癌细胞株A549细胞增殖及PTEN/AKT/mTOR信号通路表达的影响. 蚌埠医学院学报, 2020, 45(9): 1159-1162. doi: 10.13898/j.cnki.issn.1000-2200.2020.09.004
[16]	李明 , 马士恒 , 李芳 , 苏维 . 丙种球蛋白治疗重症手足口病临床效果及其对血清S-100β蛋白、NSE的影响研究. 蚌埠医学院学报, 2017, 42(8): 1045-1047. doi: 10.13898/j.cnki.issn.1000-2200.2017.08.010
[17]	姜磊 , 刘弋 . NSE和S-100在先天性巨结肠及其同源病诊断中的应用. 蚌埠医学院学报, 2012, 36(5): 525-528.
[18]	刘彬 , 汪国胜 , 钟平 , 年夫顺 , 张尊胜 . 偏头痛患者MRI亚临床病变的特点. 蚌埠医学院学报, 2015, 40(11): 1500-1502. doi: 10.13898/j.cnki.issn.1000-2200.2015.11.012
[19]	翁立军 , 张野 , 胡宪文 , 李云 . 远端预处理对体外循环下心脏瓣膜置换术患者脑损伤的保护作用. 蚌埠医学院学报, 2016, 41(1): 28-31. doi: 10.13898/j.cnki.issn.1000-2200.2016.01.007
[20]	杨军 , 台晓燕 . 血清NSE、S100B和IL-6在早产儿脑损伤的临床应用. 蚌埠医学院学报, 2019, 44(10): 1362-1364, 1369. doi: 10.13898/j.cnki.issn.1000-2200.2019.10.019

点击查看大图

计量

文章访问数: 3024
HTML全文浏览量: 573
PDF下载量: 226
被引次数: 0

血清胃泌素释放肽前体在小细胞肺癌诊断和分期中的临床意义

作者简介: 高振远(1978-),男,主治医师.

蚌埠医学院第一附属医院肿瘤内科, 安徽蚌埠 233004

收稿日期: 2013-09-21

基金项目: 蚌埠医学院科技发展基金面上项目(bykj12B25)

关键词:

摘要: 目的:探讨血清胃泌素释放肽前体(proGRP)在小细胞肺癌(SCLC)与非小细胞肺癌(NSCLC)的鉴别诊断和临床分期中的价值。方法:应用化学分析法,检测62例初诊SCLC(局限期25例,广泛期37例)、38例NSCLC患者血清proGRP水平,并与神经元特异性烯醇化酶(NSE)相对照,观察其敏感度、特异度以及与肿瘤临床分期的关系。结果:单个检测proGRP、NSE和联合检测proGRP及NSE(proGRP+NSE)诊断SCLC的敏感度分别为82.93%、64.15%和71.58%。SCLC中proGRP+NSE阳性率显著高于NSE阳性率(P<0.01),但与proGRP阳性率差异无统计学意义(P>0.05)。SCLC组患者血清proGRP和NSE水平均显著高于NSCLC组(P<0.01)。SCLC广泛期患者血清proGRP和NSE值均显著高于其局限期患者(P<0.01)。结论:proGRP作为SCLC的标志物,具有敏感度高的特点,并可反映SCLC的分期。proGRP和NSE联合检测可提高SCLC诊断的准确率。

English Abstract

The clinical significance of serum progastrin releasing peptide in the diagnosis and staging of small cell lung cancer

Department of Oncology, The First Affiliated Hospital of Bengbu Medical College, Bengbu Anhui 233004, China

Received Date: 2013-09-21

Abstract: Objective:To explore the clinical value of the levels of serum progastrin releasing peptide(proGRP) in the differential diagnosis and clinical staging of small cell lung cancer(SCLC) and non-small cell lung cancer(NSCLC).Methods:The serum levels of proGRP in 62 patients with SCLC(including 25 cases of limited stage and 37 cases of extensive stage) and 38 patients with NSCLC were measured by chemiluminescent immunoassay, which was compared with neuron specific enolase(NSE).The sensitivity, specificity and tumor staging in all patients were analyzed.Results:The sensitivities of the single detection of proGRP, NSE and combination detection of proGRP and NSE in diagnosing SCLC were 82.93%, 64.15% and 71.58%, respectively.The positive rate of the combination detection of proGRP and NSE in diagnosing SCLC was significantly higher than that of the single detection of NSE, the difference of the positive rate between combination detection proGRP and NSE and single detection of proGRP was not statistically significant(P>0.05).The serum levels of proGRP and NSE in patients with SCLC were obviously higher than those in NSCLC patients(P<0.01).Among the SCLC patients, the serum levels of proGRP and NSE in extensive stage patients were significantly higher than those in limited stage patients(P<0.01).Conclusions:The ProGRP is a tumor marker of SCLC, which is high sensitivity and specificity, and can reflect the staging.The combination detection of proGRP and NSE can improve the accurate rate of SCLC diganosis.